Quetiapine Fumarate Patent Expiration
Quetiapine Fumarate is Used for treating major depressive disorder (MDD) and schizophrenia. It was first introduced by Astrazeneca Pharmaceuticals Lp
Quetiapine Fumarate Patents
Given below is the list of patents protecting Quetiapine Fumarate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Seroquel Xr |
US5948437 (Pediatric) | Pharmaceutical compositions using thiazepine |
Nov 28, 2017
(Expired) | Astrazeneca |
Seroquel Xr | US5948437 | Pharmaceutical compositions using thiazepine |
May 28, 2017
(Expired) | Astrazeneca |
Quetiapine Fumarate's Family Patents
Explore Our Curated Drug Screens
Quetiapine Fumarate Generic API Manufacturers
Several generic applications have been filed for Quetiapine Fumarate. The first generic version for Quetiapine Fumarate was by Teva Pharmaceuticals Usa and was approved on Mar 27, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 20, 2024.
Given below is the list of companies who have filed for Quetiapine Fumarate generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 1, 2016 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
2. ACTAVIS GRP PTC
Actavis Group Ptc Ehf has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Actavis Grp Ptc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 200MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
EQ 300MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
3. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 200MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
EQ 300MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Oct 28, 2014 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
4. ALIGNSCIENCE PHARMA
Alignscience Pharma Inc has filed for 2 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alignscience Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2018 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2018 |
5. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
EQ 150MG BASE | tablet | Prescription | ORAL | AB | Feb 12, 2013 |
6. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 26, 2018 |
7. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
8. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
9. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
10. ENDO OPERATIONS
Endo Operations Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 1, 2017 |
EQ 300MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 1, 2017 |
EQ 200MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 1, 2017 |
EQ 150MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 1, 2017 |
EQ 50MG BASE | tablet, extended release | Discontinued | ORAL | N/A | May 9, 2017 |
11. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Jun 16, 2022 |
12. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
13. INTELLIPHARMACEUTICS
Intellipharmaceutics Corp has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Intellipharmaceutics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
Manufacturing Plant Locations New
Intellipharmaceutics's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Intellipharmaceutics as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Canada |
|
14. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | May 20, 2024 |
15. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Nov 26, 2013 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
16. LUPIN LTD
Lupin Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2017 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2017 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2017 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
17. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | May 17, 2016 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 17, 2016 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 17, 2016 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
18. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
19. NOVAST LABS
Novast Laboratories Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Novast Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
20. PHARMADAX INC
Pharmadax Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Pharmadax Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | May 9, 2017 |
Manufacturing Plant Locations New
Pharmadax Inc's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Pharmadax Inc as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Taiwan |
|
21. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Aug 24, 2022 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Aug 24, 2022 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 26, 2022 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Aug 24, 2022 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Mar 11, 2024 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Aug 24, 2022 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Aug 24, 2022 |
22. RISING
Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 400MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 2, 2021 |
EQ 300MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 2, 2021 |
EQ 200MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 2, 2021 |
EQ 50MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 2, 2021 |
EQ 150MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 2, 2021 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
23. SANDOZ
Sandoz Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 200MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 300MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Dec 14, 2012 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
24. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 16, 2018 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 29, 2017 |
25. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||||
India |
|
26. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 50MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 150MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
EQ 200MG BASE | tablet | Prescription | ORAL | AB | Mar 27, 2012 |
27. TORRENT PHARMS LTD
Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 300MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
EQ 200MG BASE | tablet | Discontinued | ORAL | N/A | Mar 27, 2012 |
28. UNICHEM
Unichem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Unichem.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 100MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2016 |
EQ 200MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 15, 2022 |
EQ 300MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 15, 2022 |
EQ 400MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 15, 2022 |
EQ 25MG BASE | tablet | Prescription | ORAL | AB | Mar 8, 2016 |
EQ 50MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 15, 2022 |
EQ 150MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 15, 2022 |
Manufacturing Plant Locations New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||||
United States |
|